You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

ZELAPAR Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Zelapar patents expire, and when can generic versions of Zelapar launch?

Zelapar is a drug marketed by Bausch and is included in one NDA.

The generic ingredient in ZELAPAR is selegiline hydrochloride. There are seventeen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the selegiline hydrochloride profile page.

Drug patent expirations by year for ZELAPAR
Drug Prices for ZELAPAR

See drug prices for ZELAPAR

Recent Clinical Trials for ZELAPAR

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of South FloridaPhase 4
Bausch Health Americas, Inc.Phase 4
Parkinson's Disease and Movement Disorder Center of Boca RatonPhase 4

See all ZELAPAR clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for ZELAPAR

US Patents and Regulatory Information for ZELAPAR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch ZELAPAR selegiline hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 021479-001 Jun 14, 2006 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ZELAPAR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bausch ZELAPAR selegiline hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 021479-001 Jun 14, 2006 ⤷  Try a Trial ⤷  Try a Trial
Bausch ZELAPAR selegiline hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 021479-001 Jun 14, 2006 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for ZELAPAR

See the table below for patents covering ZELAPAR around the world.

Country Patent Number Title Estimated Expiration
Spain 2136662 ⤷  Try a Trial
Romania 112990 FORMA DE DOZARE SOLIDA (SOLID DOSAGE FORM) ⤷  Try a Trial
Spain 2160232 ⤷  Try a Trial
El Salvador 1998000062 FORMULACIONES FARMACEUTICAS Y OTRAS REF. JAB 865 ⤷  Try a Trial
Denmark 0460185 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.